Seelos therapeutics raises $10 million in private placement of senior secured convertible note

New york, dec. 14, 2020 /prnewswire/ -- seelos therapeutics, inc. (nasdaq: seel), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced the sale of a $12.0 million senior secured...
SEEL Ratings Summary
SEEL Quant Ranking